Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDGL Madrigal Pharmaceuticals, Inc.

未开盘 05-08 16:00:00 EDT

208.04

-9.92

-4.55%

盘后208.04

+0.000.00%

18:49 EDT

最高215.00	最低201.50	成交量69.05万
今开211.52	昨收217.96	日振幅6.19%
总市值44.28亿	流通市值28.04亿	总股本2,128万
成交额1.43亿	换手率5.12%	流通股本1,348万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals, Inc.","latestPrice":208.04,"timestamp":1715198400000,"preClose":217.96,"halted":0,"volume":690496,"hourTrading":{"tag":"盘后","latestPrice":208.04,"preClose":208.04,"latestTime":"18:49 EDT","volume":2735,"amount":568916.3,"timestamp":1715208568042},"delay":0,"floatShares":13479170,"shares":21284598,"eps":-23.210423,"marketStatus":"未开盘","marketStatusCode":0,"change":-9.92,"latestTime":"05-08 16:00:00 EDT","open":211.52,"high":215,"low":201.5001,"amount":143028816.66304,"amplitude":0.061938,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-23.210423,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715241600000},"adr":0,"adjPreClose":217.96,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":212.17,"preClose":217.96,"latestTime":"09:28 EDT","volume":244,"amount":52116.77008,"timestamp":1715174880005},"postHourTrading":{"tag":"盘后","latestPrice":208.04,"preClose":208.04,"latestTime":"18:49 EDT","volume":2735,"amount":568916.3,"timestamp":1715208568042},"volumeRatio":1.367199},"requestUrl":"/m/hq/s/MDGL/tweets","defaultTab":"tweets","newsList":[{"id":"2434770047","title":"花旗：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由389.00美元调整至382.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434770047","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434770047?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:25","pubTimestamp":1715196337,"startTime":"0","endTime":"0","summary":"花旗：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由389.00美元调整至382.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903254187e16f56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903254187e16f56&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434521772","title":"摩根大通证券公司：维持Madrigal Pharmaceuticals(MDGL.US)评级，由优于大市调整至优于大市评级, 目标价由397.00美元调整至381.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434521772","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434521772?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:05","pubTimestamp":1715191510,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Madrigal Pharmaceuticals(MDGL.US)评级，由优于大市调整至优于大市评级, 目标价由397.00美元调整至381.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902051387e13dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902051387e13dd4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433572709","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433572709","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433572709?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:29","pubTimestamp":1715178590,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时29分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.03%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 、Cel-Sci Corporation涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为230.45%、61.59%、25.16%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Chemomab Therapeutics Ltd，振幅分别为60.74%、43.00%、33.42%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508222952861ebcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508222952861ebcce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433785108","title":"BUZZ-Madrigal 因最近获批上市的 NASH 药物细节 \"不足 \"而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2433785108","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433785108?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:17","pubTimestamp":1715091434,"startTime":"0","endTime":"0","summary":"** 虽然没有对 Rezdiffra 第一季度的收入做出预期，但投资者希望 \"在具体的患者人数或新处方量方面获得更多有关上市进展的信息，\"Mamtani 说。** 由于与 Rezdiffra 有关的生产和上市相关成本的时间安排，公司第一季度的运营支出几乎翻了一番，达到 1.5204 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433788234","title":"Madrigal 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433788234","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433788234?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:53","pubTimestamp":1715089993,"startTime":"0","endTime":"0","summary":"   * Madrigal Pharmaceuticals Inc   报告，截至3月底的季度调整后每股亏损7.38美元，低于去年同期的每股收益4.23美元。13位分析师对该季度的平均预期是每股亏损6.28美元。华尔街预期为每股亏损 7.34 美元至 4.86 美元。* Madrigal Pharmaceuticals Inc 报告的季度每股收益为亏损 7.38 美元。* 该公司一季度亏损 1.4754 亿美元。* Madrigal Pharmaceuticals Inc 的股价本季度下跌了 11.8%，今年迄今为止上涨了 1.8%。华尔街对 Madrigal Pharmaceuticals Inc 的 12 个月目标价中位数为 390.00 美元。本摘要由 LSEG 数据于世界协调时 5 月 7 日下午 01:52 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433658788","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.33%报223.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433658788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433658788?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:34","pubTimestamp":1715088846,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时34分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.33%。截至发稿，该股报223.01美元/股，成交量3.5187万股，换手率0.17%，振幅2.13%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nanoviricides, Inc.涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为929.65%、94.94%、32.34%，振幅较大的相关个股有Clearmind Medicine Inc.、Nanoviricides, Inc.、Heron Therapeutics, Inc.，振幅分别为21.37%、12.14%、11.97%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721340687dc9f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721340687dc9f84&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432098319","title":"Madrigal Pharmaceuticals Inc   预计每股亏损6.28美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432098319","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432098319?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:34","pubTimestamp":1714746892,"startTime":"0","endTime":"0","summary":"   * Madrigal Pharmaceuticals Inc    将于5月7日公布截至2024年3月31日的财报，预计季度营收将保持不变。*    * LSEG分析师对Madrigal Pharmaceuticals Inc的平均预期是每股亏损6.28美元。* 华尔街对 Madrigal Pharmaceuticals Inc 的 12 个月目标价中位数为 390.00 美元，高于其上次收盘价 216.05 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432905515","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432905515","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432905515?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:53","pubTimestamp":1714744428,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时53分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.30%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Vaxxinity, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为110.88%、27.98%、18.65%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Effector Therapeutics Inc C/Wts 31/12/2025 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为54.50%、30.65%、26.55%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032153497a57fbef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032153497a57fbef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432863304","title":"Madrigal Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432863304","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432863304?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:53","pubTimestamp":1714589583,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时53分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.08%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.99%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1411.73%、1199.87%、264.60%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020253047925a4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020253047925a4e2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431197810","title":"Madrigal Pharmaceuticals, Inc.涨3.48% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2431197810","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431197810?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:21","pubTimestamp":1714414899,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日02时21分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速上涨3.48%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Zura Bio Limited C/Wts 、Calidi Biotherapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Zyversa Therapeutics, Inc.、Annovis Bio, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1014.19%、76.74%、62.39%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Annovis Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为98.32%、79.12%、75.06%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043002213979251704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043002213979251704&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430286719","title":"Madrigal Pharmaceuticals, Inc.跌2.37% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286719","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286719?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:35","pubTimestamp":1714052150,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时35分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价快速下跌2.37%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下：Madrigal Pharmaceuticals获B of A Securities首次覆盖，给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213550861e9088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213550861e9088&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429191631","title":"Madrigal Pharmaceuticals, Inc.盘中异动 急速拉升5.05%报224.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429191631","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429191631?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:50","pubTimestamp":1713883848,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时50分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.05%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下：Madrigal Pharmaceuticals获B of A Securities首次覆盖，给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232250487922b450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232250487922b450&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429973103","title":"BUZZ-美国银行将 Madrigal Pharma 评级定为 \"跑输大市\"，该公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429973103","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429973103?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:35","pubTimestamp":1713800134,"startTime":"0","endTime":"0","summary":"    4月22日 - ** Madrigal Pharmaceuticals   股价下跌 6.3% 至 198.69 美元** BofA 券商给予该公司 \"跑输大市 \"评级，目标价为 150 美元。)** BofA 预测峰值销售额为 41 亿美元，低于 55 亿美元的一致预期。** MDGL 股价今年以来下跌约 11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429973508","title":"Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报201.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429973508","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429973508?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:12","pubTimestamp":1713798744,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时12分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.01%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下：Madrigal Pharmaceuticals获B of A Securities首次覆盖，给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042223122479225f4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042223122479225f4e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429994954","title":"Madrigal Pharmaceuticals(MDGL.US)获B of A Securities首次覆盖，给予低于大市评级, 目标价150.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429994954","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429994954?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:35","pubTimestamp":1713782115,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals(MDGL.US)获B of A Securities首次覆盖，给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221835178b45cc14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221835178b45cc14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428662791","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428662791","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428662791?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:33","pubTimestamp":1713547998,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时33分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.07%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Nkgen Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为241.62%、15.55%、14.71%，振幅较大的相关个股有Nkgen Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为62.28%、46.41%、38.01%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420013318861e780c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420013318861e780c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424492190","title":"Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424492190","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424492190?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:08","pubTimestamp":1712066913,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时08分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.05%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.81%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至22时08分，《Form 144 | Madrigal Pharmaceuticals董事拟出售1.1万股股份，价值约293.74万美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间4月1日披露的文件，$Madrigal Pharmaceuticals $董事RICHARD S LEVY拟于4月1日出售1.1万股普通股股份，总市值约293.74万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421384518","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.05%报242.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421384518","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421384518?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:22","pubTimestamp":1711120946,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时22分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.05%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Effector Therapeutics Inc C/Wts 31/12/2025 、Virios Therapeutics, Inc.涨幅较大，Outlook Therapeutics, Inc.、180 Life Sciences Corp.、安皮奥制药较为活跃，换手率分别为79.43%、36.30%、21.42%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts ，振幅分别为59.24%、43.92%、42.98%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322232227791c517d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322232227791c517d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420723943","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420723943","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420723943?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:47","pubTimestamp":1710942449,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时47分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.14%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Nls Pharmaceutics Ltd.较为活跃，换手率分别为46.89%、34.19%、16.36%，振幅较大的相关个股有Taysha Gene Therapies, Inc.、Nls Pharmaceutics Ltd.、Tff Pharmaceuticals, Inc.，振幅分别为25.16%、24.83%、21.42%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032021473087e7a66c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032021473087e7a66c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420278079","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.03%报268.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420278079","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420278079?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:18","pubTimestamp":1710857902,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时18分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.03%。截至发稿，该股报268.98美元/股，成交量29.0796万股，换手率1.46%，振幅2.88%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、Enveric Biosciences, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为758.58%、376.67%、133.76%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为44.55%、31.07%、30.00%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922182387e7a164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922182387e7a164&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.1633},{"period":"3month","weight":0.214},{"period":"6month","weight":0.4984},{"period":"1year","weight":-0.3057},{"period":"ytd","weight":-0.1009}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司，致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命，包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.032263},{"month":2,"riseRate":0.75,"avgChangeRate":0.088162},{"month":3,"riseRate":0.25,"avgChangeRate":-0.038862},{"month":4,"riseRate":0.5,"avgChangeRate":0.008688},{"month":5,"riseRate":0.375,"avgChangeRate":0.151593},{"month":6,"riseRate":0.571429,"avgChangeRate":0.00101},{"month":7,"riseRate":0,"avgChangeRate":-0.103727},{"month":8,"riseRate":0.625,"avgChangeRate":0.081916},{"month":9,"riseRate":0.375,"avgChangeRate":0.16708},{"month":10,"riseRate":0.625,"avgChangeRate":0.051439},{"month":11,"riseRate":0.5,"avgChangeRate":0.037474},{"month":12,"riseRate":0.5,"avgChangeRate":0.475789}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals, Inc.","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Madrigal Pharmaceuticals, Inc.,MDGL,Madrigal Pharmaceuticals, Inc.股票,Madrigal Pharmaceuticals, Inc.股票老虎,Madrigal Pharmaceuticals, Inc.股票老虎国际,Madrigal Pharmaceuticals, Inc.行情,Madrigal Pharmaceuticals, Inc.股票行情,Madrigal Pharmaceuticals, Inc.股价,Madrigal Pharmaceuticals, Inc.股市,Madrigal Pharmaceuticals, Inc.股票价格,Madrigal Pharmaceuticals, Inc.股票交易,Madrigal Pharmaceuticals, Inc.股票购买,Madrigal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}